Imed Infinity Medical-Limited Partnership
Tel Aviv Stock Exchange IMED.TA
Imed Infinity Medical-Limited Partnership Shares (Diluted, Weighted) for the year ending December 31, 2023
Imed Infinity Medical-Limited Partnership Shares (Diluted, Weighted) is NA for the year ending December 31, 2023. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
-
Imed Infinity Medical-Limited Partnership Shares (Diluted, Weighted) for the year ending December 31, 2022 was 4,024,000, a -0.19% change year over year.
-
Imed Infinity Medical-Limited Partnership Shares (Diluted, Weighted) for the year ending December 31, 2021 was 4,031,577.
Key data
| Date | Shares (Diluted, Weighted) | Revenue | Cost of Revenue | Gross Profit |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: IMED.TA
| CEO | Mr. Itay Gal-Or |
| IPO Date | Jan. 4, 2021 |
| Location | Israel |
| Headquarters | Azrieli Tower |
| Employees | 55 |
| Sector | Industrials |
| Industries | |
Description
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email